JP2022516555A5 - - Google Patents

Info

Publication number
JP2022516555A5
JP2022516555A5 JP2021538976A JP2021538976A JP2022516555A5 JP 2022516555 A5 JP2022516555 A5 JP 2022516555A5 JP 2021538976 A JP2021538976 A JP 2021538976A JP 2021538976 A JP2021538976 A JP 2021538976A JP 2022516555 A5 JP2022516555 A5 JP 2022516555A5
Authority
JP
Japan
Application number
JP2021538976A
Other languages
Japanese (ja)
Other versions
JP2022516555A (ja
JPWO2020142742A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/012260 external-priority patent/WO2020142742A1/en
Publication of JP2022516555A publication Critical patent/JP2022516555A/ja
Publication of JP2022516555A5 publication Critical patent/JP2022516555A5/ja
Publication of JPWO2020142742A5 publication Critical patent/JPWO2020142742A5/ja
Pending legal-status Critical Current

Links

JP2021538976A 2019-01-04 2020-01-03 線維芽細胞活性化タンパク質の阻害剤 Pending JP2022516555A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962788722P 2019-01-04 2019-01-04
US62/788,722 2019-01-04
US201962863853P 2019-06-19 2019-06-19
US62/863,853 2019-06-19
PCT/US2020/012260 WO2020142742A1 (en) 2019-01-04 2020-01-03 Inhibitors of fibroblast activation protein

Publications (3)

Publication Number Publication Date
JP2022516555A JP2022516555A (ja) 2022-02-28
JP2022516555A5 true JP2022516555A5 (https=) 2023-01-11
JPWO2020142742A5 JPWO2020142742A5 (https=) 2023-01-11

Family

ID=71404153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021538976A Pending JP2022516555A (ja) 2019-01-04 2020-01-03 線維芽細胞活性化タンパク質の阻害剤

Country Status (13)

Country Link
US (1) US20200216417A1 (https=)
EP (1) EP3906024A4 (https=)
JP (1) JP2022516555A (https=)
KR (1) KR20210113634A (https=)
CN (1) CN114126597A (https=)
AU (1) AU2020204714A1 (https=)
BR (1) BR112021011861A2 (https=)
CA (1) CA3124525A1 (https=)
CL (1) CL2021001739A1 (https=)
IL (1) IL284434A (https=)
MX (1) MX2021007948A (https=)
SG (1) SG11202106399XA (https=)
WO (1) WO2020142742A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116474108A (zh) 2016-12-14 2023-07-25 普渡研究基金会 成纤维细胞活化蛋白(fap)-靶向成像和治疗
JP2021506972A (ja) 2017-12-15 2021-02-22 プラクシス バイオテック エルエルシー 線維芽細胞活性化タンパク質の阻害剤
EP3728228A1 (en) 2017-12-22 2020-10-28 Ravenna Pharmaceuticals, Inc. Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
CN113811529A (zh) 2018-12-21 2021-12-17 普拉西斯生物技术有限责任公司 成纤维细胞激活蛋白抑制剂
TW202112767A (zh) 2019-06-17 2021-04-01 美商佩特拉製藥公司 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
WO2020254559A1 (en) 2019-06-19 2020-12-24 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
WO2021155292A1 (en) * 2020-01-31 2021-08-05 Philip Stewart Low Fibroblast activation protein (fap) - targeted antifibrotic therapy
CN119798158B (zh) * 2022-08-02 2025-10-17 中国科学院上海应用物理研究所 一种含苯并吡啶环类化合物及其制备方法
WO2025159534A1 (ko) * 2024-01-24 2025-07-31 서울대학교산학협력단 3-스티릴피리딘 구조 기반의 섬유아세포 활성화 단백질 표적 물질
CN118978511A (zh) * 2024-08-02 2024-11-19 江苏华益科技有限公司 一种靶向fap化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1943257A2 (en) * 2005-05-19 2008-07-16 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods
AU2006278039B2 (en) * 2005-08-11 2010-10-21 F. Hoffmann-La Roche Ag Pharmaceutical composition comprising a DPP-lV inhibitor
WO2013107820A1 (en) * 2012-01-17 2013-07-25 Universiteit Antwerpen Novel fap inhibitors
JP2021506972A (ja) * 2017-12-15 2021-02-22 プラクシス バイオテック エルエルシー 線維芽細胞活性化タンパク質の阻害剤
CN113811529A (zh) * 2018-12-21 2021-12-17 普拉西斯生物技术有限责任公司 成纤维细胞激活蛋白抑制剂

Similar Documents

Publication Publication Date Title
JP2022516555A5 (https=)
CN306348783S (https=)
CN306299448S (https=)
CN305580314S (https=)
CN305580329S (https=)
CN305668770S (https=)
CN305670904S (https=)
CN305707421S (https=)
CN305723566S (https=)
CN305724072S (https=)
CN305724701S (https=)
CN305749303S (https=)
CN305793313S (https=)
CN305794455S (https=)
CN305797222S (https=)
CN305798241S (https=)
CN305798593S (https=)
CN305799080S (https=)
CN305804390S (https=)
CN305829074S (https=)
CN305829769S (https=)
CN306142821S (https=)
CN306183333S (https=)
CN306193571S (https=)
CN306194597S (https=)